Tag: Eisai
Eisai reports comparable drug exposure with subcutaneous lecanemab initiation regimen
Data presented at AAIC 2026 support further evaluation of a once-weekly 500 mg autoinjector regimen as an alternative to intravenous initiation in early Alzheimer’s...
Four pharma giants join hands to reduce environmental burden in pharma...
Astellas, Eisai, Daiichi Sankyo, and Takeda aim to ensure that society benefits from this collaboration to harmonize corporate activities with the global environment